Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral theophylline versus Ergotamine-C for post-dural puncture headache after cesarean section
IRCT20120915010841N14Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of theophylline and ergotamine in post-dural puncture headache (PDPH) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Headache. Started Jan 2019; status: completed.
02
Drugs
theophyllineergotamine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20120915010841N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120915010841N14.